Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 270

1.

Discriminative power of intra-retinal layers in early multiple sclerosis using 3D OCT imaging.

Seitz CB, Droby A, Zaubitzer L, Krämer J, Paradis M, Klotz L, Wiendl H, Groppa S, Meuth SG, Zipp F, Fleischer V.

J Neurol. 2018 Aug 2. doi: 10.1007/s00415-018-8988-3. [Epub ahead of print]

PMID:
30073502
2.

Targeting prohibitins at the cell surface prevents Th17-mediated autoimmunity.

Buehler U, Schulenburg K, Yurugi H, Šolman M, Abankwa D, Ulges A, Tenzer S, Bopp T, Thiede B, Zipp F, Rajalingam K.

EMBO J. 2018 Aug 15;37(16). pii: e99429. doi: 10.15252/embj.201899429. Epub 2018 Jul 26.

PMID:
30049713
3.

GFAPα IgG-associated encephalitis upon daclizumab treatment of MS.

Luessi F, Engel S, Spreer A, Bittner S, Zipp F.

Neurol Neuroimmunol Neuroinflamm. 2018 Jul 13;5(5):e481. doi: 10.1212/NXI.0000000000000481. eCollection 2018 Sep.

4.

DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis.

Kular L, Liu Y, Ruhrmann S, Zheleznyakova G, Marabita F, Gomez-Cabrero D, James T, Ewing E, Lindén M, Górnikiewicz B, Aeinehband S, Stridh P, Link J, Andlauer TFM, Gasperi C, Wiendl H, Zipp F, Gold R, Tackenberg B, Weber F, Hemmer B, Strauch K, Heilmann-Heimbach S, Rawal R, Schminke U, Schmidt CO, Kacprowski T, Franke A, Laudes M, Dilthey AT, Celius EG, Søndergaard HB, Tegnér J, Harbo HF, Oturai AB, Olafsson S, Eggertsson HP, Halldorsson BV, Hjaltason H, Olafsson E, Jonsdottir I, Stefansson K, Olsson T, Piehl F, Ekström TJ, Kockum I, Feinberg AP, Jagodic M.

Nat Commun. 2018 Jun 19;9(1):2397. doi: 10.1038/s41467-018-04732-5.

5.

AAN unveils new guidelines for MS disease-modifying therapy.

Bittner S, Zipp F.

Nat Rev Neurol. 2018 Jun 12. doi: 10.1038/s41582-018-0026-7. [Epub ahead of print] No abstract available.

PMID:
29895963
6.

[New aspects of immunotherapy in multiple sclerosis].

Pape K, Zipp F, Bittner S.

Nervenarzt. 2018 Jun 7. doi: 10.1007/s00115-018-0542-0. [Epub ahead of print] Review. German.

PMID:
29881971
7.

Monitoring B-cell repopulation after depletion therapy in neurologic patients.

Ellwardt E, Ellwardt L, Bittner S, Zipp F.

Neurol Neuroimmunol Neuroinflamm. 2018 Apr 25;5(4):e463. doi: 10.1212/NXI.0000000000000463. eCollection 2018 Jul.

8.

Characterizing Microstructural Tissue Properties in Multiple Sclerosis with Diffusion MRI at 7 T and 3 T: The Impact of the Experimental Design.

De Santis S, Bastiani M, Droby A, Kolber P, Zipp F, Pracht E, Stoecker T, Groppa S, Roebroeck A.

Neuroscience. 2018 Apr 7. pii: S0306-4522(18)30248-3. doi: 10.1016/j.neuroscience.2018.03.048. [Epub ahead of print]

9.

CCR7 on CD4+ T Cells Plays a Crucial Role in the Induction of Experimental Autoimmune Encephalomyelitis.

Belikan P, Bühler U, Wolf C, Pramanik GK, Gollan R, Zipp F, Siffrin V.

J Immunol. 2018 Apr 15;200(8):2554-2562. doi: 10.4049/jimmunol.1701419. Epub 2018 Mar 16.

PMID:
29549177
10.

Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.

Siller N, Kuhle J, Muthuraman M, Barro C, Uphaus T, Groppa S, Kappos L, Zipp F, Bittner S.

Mult Scler. 2018 Mar 1:1352458518765666. doi: 10.1177/1352458518765666. [Epub ahead of print]

PMID:
29542376
11.

Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis.

Graetz C, Gröger A, Luessi F, Salmen A, Zöller D, Schultz J, Siller N, Fleischer V, Bellenberg B, Berthele A, Biberacher V, Havla J, Hecker M, Hohlfeld R, Infante-Duarte C, Kirschke JS, Kümpfel T, Linker R, Paul F, Pfeuffer S, Sämann P, Toenges G, Weber F, Zettl UK, Jahn-Eimermacher A, Antony G, Groppa S, Wiendl H, Hemmer B, Mühlau M, Lukas C, Gold R, Lill CM, Zipp F.

Mult Scler. 2018 Mar 1:1352458518763541. doi: 10.1177/1352458518763541. [Epub ahead of print]

PMID:
29532745
12.

Treatment choices and neuropsychological symptoms of a large cohort of early MS.

von Bismarck O, Dankowski T, Ambrosius B, Hessler N, Antony G, Ziegler A, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Tackenberg B, Stoppe M, Then Bergh F, Tumani H, Kümpfel T, Stangel M, Heesen C, Wildemann B, Paul F, Bayas A, Warnke C, Weber F, Linker RA, Ziemann U, Zettl UK, Zipp F, Wiendl H, Hemmer B, Gold R, Salmen A.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 1;5(3):e446. doi: 10.1212/NXI.0000000000000446. eCollection 2018 May.

13.

Studying the blood-brain barrier will provide new insights into neurodegeneration - Commentary.

Bittner S, Zipp F.

Mult Scler. 2018 Jul;24(8):1026-1028. doi: 10.1177/1352458518759430. Epub 2018 Mar 5. No abstract available.

PMID:
29504451
14.

Fast direct neuronal signaling via the IL-4 receptor as therapeutic target in neuroinflammation.

Vogelaar CF, Mandal S, Lerch S, Birkner K, Birkenstock J, Bühler U, Schnatz A, Raine CS, Bittner S, Vogt J, Kipnis J, Nitsch R, Zipp F.

Sci Transl Med. 2018 Feb 28;10(430). pii: eaao2304. doi: 10.1126/scitranslmed.aao2304.

PMID:
29491183
15.

EGFL7 reduces CNS inflammation in mouse.

Larochelle C, Uphaus T, Broux B, Gowing E, Paterka M, Michel L, Dudvarski Stankovic N, Bicker F, Lemaître F, Prat A, Schmidt MHH, Zipp F.

Nat Commun. 2018 Feb 26;9(1):819. doi: 10.1038/s41467-018-03186-z.

16.

Preservation of neuronal function as measured by clinical and MRI endpoints in relapsing-remitting multiple sclerosis: how effective are current treatment strategies?

Graetz C, Groppa S, Zipp F, Siller N.

Expert Rev Neurother. 2018 Mar;18(3):203-219. doi: 10.1080/14737175.2018.1438190. Epub 2018 Feb 15.

PMID:
29411688
17.

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F.

Mult Scler. 2018 Feb;24(2):96-120. doi: 10.1177/1352458517751049. Epub 2018 Jan 20.

PMID:
29353550
18.

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

Montalban X, Gold R, Thompson AJ, Otero-Romero S, Amato MP, Chandraratna D, Clanet M, Comi G, Derfuss T, Fazekas F, Hartung HP, Havrdova E, Hemmer B, Kappos L, Liblau R, Lubetzki C, Marcus E, Miller DH, Olsson T, Pilling S, Selmaj K, Siva A, Sorensen PS, Sormani MP, Thalheim C, Wiendl H, Zipp F.

Eur J Neurol. 2018 Feb;25(2):215-237. doi: 10.1111/ene.13536. Epub 2018 Jan 19. Erratum in: Eur J Neurol. 2018 Mar;25(3):605.

PMID:
29352526
19.

Increased cerebrospinal fluid albumin and immunoglobulin A fractions forecast cortical atrophy and longitudinal functional deterioration in relapsing-remitting multiple sclerosis.

Kroth J, Ciolac D, Fleischer V, Koirala N, Krämer J, Muthuraman M, Luessi F, Bittner S, Gonzalez-Escamilla G, Zipp F, Meuth SG, Groppa S.

Mult Scler. 2017 Dec 1:1352458517748474. doi: 10.1177/1352458517748474. [Epub ahead of print]

PMID:
29226779
20.

Graph Theoretical Framework of Brain Networks in Multiple Sclerosis: A Review of Concepts.

Fleischer V, Radetz A, Ciolac D, Muthuraman M, Gonzalez-Escamilla G, Zipp F, Groppa S.

Neuroscience. 2017 Nov 1. pii: S0306-4522(17)30761-3. doi: 10.1016/j.neuroscience.2017.10.033. [Epub ahead of print]

PMID:
29101079
21.

Disease reactivation after switching from natalizumab to daclizumab.

Uphaus T, Oberwittler C, Groppa S, Zipp F, Bittner S.

J Neurol. 2017 Dec;264(12):2491-2494. doi: 10.1007/s00415-017-8622-9. Epub 2017 Oct 3.

PMID:
28975400
22.

The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis.

Birkner K, Wasser B, Loos J, Plotnikov A, Seger R, Zipp F, Witsch E, Bittner S.

Int J Mol Sci. 2017 Sep 15;18(9). pii: E1990. doi: 10.3390/ijms18091990.

23.

Single-cell profiling reveals GPCR heterogeneity and functional patterning during neuroinflammation.

Tischner D, Grimm M, Kaur H, Staudenraus D, Carvalho J, Looso M, Günther S, Wanke F, Moos S, Siller N, Breuer J, Schwab N, Zipp F, Waisman A, Kurschus FC, Offermanns S, Wettschureck N.

JCI Insight. 2017 Aug 3;2(15). pii: 95063. doi: 10.1172/jci.insight.95063. [Epub ahead of print]

24.

Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria.

Preziosa P, Rocca MA, Mesaros S, Meani A, Montalban X, Drulovic J, Droby A, Zipp F, Calabrese M, Sastre-Garriga J, Dujmovic-Basuroski I, Rovira A, Filippi M.

J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):316-318. doi: 10.1136/jnnp-2017-315863. Epub 2017 Jul 19. No abstract available.

PMID:
28724720
25.

A Novel Cervical Spinal Cord Window Preparation Allows for Two-Photon Imaging of T-Cell Interactions with the Cervical Spinal Cord Microvasculature during Experimental Autoimmune Encephalomyelitis.

Haghayegh Jahromi N, Tardent H, Enzmann G, Deutsch U, Kawakami N, Bittner S, Vestweber D, Zipp F, Stein JV, Engelhardt B.

Front Immunol. 2017 Apr 11;8:406. doi: 10.3389/fimmu.2017.00406. eCollection 2017.

26.

Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.

Fleischer V, Friedrich M, Rezk A, Bühler U, Witsch E, Uphaus T, Bittner S, Groppa S, Tackenberg B, Bar-Or A, Zipp F, Luessi F.

Mult Scler. 2018 Apr;24(5):632-641. doi: 10.1177/1352458517703799. Epub 2017 Apr 24.

PMID:
28436295
27.

A "kissing lesion": In-vivo 7T evidence of meningeal inflammation in early multiple sclerosis.

Kolber P, Droby A, Roebroeck A, Goebel R, Fleischer V, Groppa S, Zipp F.

Mult Scler. 2017 Jul;23(8):1167-1169. doi: 10.1177/1352458516683267. Epub 2017 Apr 18.

PMID:
28417657
28.

Dimethyl fumarate-induced lymphopenia in MS due to differential T-cell subset apoptosis.

Ghadiri M, Rezk A, Li R, Evans A, Luessi F, Zipp F, Giacomini PS, Antel J, Bar-Or A.

Neurol Neuroimmunol Neuroinflamm. 2017 Mar 23;4(3):e340. doi: 10.1212/NXI.0000000000000340. eCollection 2017 May.

29.

Functional connectivity analysis using whole brain and regional network metrics in MS patients.

Chirumamilla VC, Fleischer V, Droby A, Anjum T, Muthuraman M, Zipp F, Groppa S.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:4039-4042. doi: 10.1109/EMBC.2016.7591613.

PMID:
28269169
30.

Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.

Li R, Rezk A, Ghadiri M, Luessi F, Zipp F, Li H, Giacomini PS, Antel J, Bar-Or A.

J Immunol. 2017 Jan 15;198(2):691-698. doi: 10.4049/jimmunol.1601649. Epub 2016 Dec 14.

31.

No role of IFITM3 in brain tumor formation in vivo.

Stankovic ND, Hoppmann N, Teodorczyk M, Kim EL, Bros M, Giese A, Zipp F, Schmidt MHH.

Oncotarget. 2016 Dec 27;7(52):86388-86405. doi: 10.18632/oncotarget.13199.

32.

Phenotype of Antigen Unexperienced TH Cells in the Inflamed Central Nervous System in Experimental Autoimmune Encephalomyelitis.

Franck S, Paterka M, Birkenstock J, Zipp F, Siffrin V, Witsch E.

J Neuroimmune Pharmacol. 2017 Jun;12(2):305-313. doi: 10.1007/s11481-016-9718-1. Epub 2016 Nov 10.

PMID:
27832402
33.

Fortschritte in der Neuroimmunologie – Multiple Sklerose.

Zipp F.

Drug Res (Stuttg). 2016 Nov;66(S 01):S22-S23. Epub 2016 Nov 2. German. No abstract available.

PMID:
27806398
Free Article
34.

Down-regulation of neuronal L1 cell adhesion molecule expression alleviates inflammatory neuronal injury.

Menzel L, Paterka M, Bittner S, White R, Bobkiewicz W, van Horssen J, Schachner M, Witsch E, Kuhlmann T, Zipp F, Schäfer MK.

Acta Neuropathol. 2016 Nov;132(5):703-720. Epub 2016 Aug 20.

PMID:
27544757
35.

Metabolic Patterns in Chronic Multiple Sclerosis Lesions and Normal-appearing White Matter: Intraindividual Comparison by Using 2D MR Spectroscopic Imaging.

Fleischer V, Kolb R, Groppa S, Zipp F, Klose U, Gröger A.

Radiology. 2016 Nov;281(2):536-543. Epub 2016 May 30.

PMID:
27243371
36.

Past, present and future of immunology in Mainz.

Waisman A, Hövelmeyer N, Diefenbach A, Schuppan D, Reddehase MJ, Kleinert H, Kaina B, Grabbe S, Galle PR, Theobald M, Zipp F, Sahin U, Türeci Ö, Kreiter S, Langguth P, Decker H, van Zandbergen G, Schild H.

Cell Immunol. 2016 Oct;308:1-6. doi: 10.1016/j.cellimm.2016.09.001. No abstract available.

PMID:
27719802
37.

Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitis.

Paterka M, Voss JO, Werr J, Reuter E, Franck S, Leuenberger T, Herz J, Radbruch H, Bopp T, Siffrin V, Zipp F.

J Autoimmun. 2017 Jan;76:108-114. doi: 10.1016/j.jaut.2016.09.008. Epub 2016 Oct 2.

PMID:
27707650
38.

Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.

Ulges A, Witsch EJ, Pramanik G, Klein M, Birkner K, Bühler U, Wasser B, Luessi F, Stergiou N, Dietzen S, Brühl TJ, Bohn T, Bündgen G, Kunz H, Waisman A, Schild H, Schmitt E, Zipp F, Bopp T.

Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10145-50. doi: 10.1073/pnas.1523869113. Epub 2016 Aug 23.

39.

The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis.

Gracien RM, Jurcoane A, Wagner M, Reitz SC, Mayer C, Volz S, Hof SM, Fleischer V, Droby A, Steinmetz H, Zipp F, Hattingen E, Deichmann R, Klein JC.

PLoS One. 2016 Aug 11;11(8):e0161036. doi: 10.1371/journal.pone.0161036. eCollection 2016.

40.

Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment.

Bühler U, Fleischer V, Luessi F, Rezk A, Belikan P, Graetz C, Gollan R, Wolf C, Lutz J, Bar-Or A, Siffrin V, Zipp F.

Mult Scler. 2017 Apr;23(4):567-576. doi: 10.1177/1352458516658559. Epub 2016 Jul 21.

PMID:
27436357
41.

Increase of Alternatively Activated Antigen Presenting Cells in Active Experimental Autoimmune Encephalomyelitis.

Wasser B, Pramanik G, Hess M, Klein M, Luessi F, Dornmair K, Bopp T, Zipp F, Witsch E.

J Neuroimmune Pharmacol. 2016 Dec;11(4):721-732. Epub 2016 Jul 16.

PMID:
27423192
42.

Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation.

Andlauer TF, Buck D, Antony G, Bayas A, Bechmann L, Berthele A, Chan A, Gasperi C, Gold R, Graetz C, Haas J, Hecker M, Infante-Duarte C, Knop M, Kümpfel T, Limmroth V, Linker RA, Loleit V, Luessi F, Meuth SG, Mühlau M, Nischwitz S, Paul F, Pütz M, Ruck T, Salmen A, Stangel M, Stellmann JP, Stürner KH, Tackenberg B, Then Bergh F, Tumani H, Warnke C, Weber F, Wiendl H, Wildemann B, Zettl UK, Ziemann U, Zipp F, Arloth J, Weber P, Radivojkov-Blagojevic M, Scheinhardt MO, Dankowski T, Bettecken T, Lichtner P, Czamara D, Carrillo-Roa T, Binder EB, Berger K, Bertram L, Franke A, Gieger C, Herms S, Homuth G, Ising M, Jöckel KH, Kacprowski T, Kloiber S, Laudes M, Lieb W, Lill CM, Lucae S, Meitinger T, Moebus S, Müller-Nurasyid M, Nöthen MM, Petersmann A, Rawal R, Schminke U, Strauch K, Völzke H, Waldenberger M, Wellmann J, Porcu E, Mulas A, Pitzalis M, Sidore C, Zara I, Cucca F, Zoledziewska M, Ziegler A, Hemmer B, Müller-Myhsok B.

Sci Adv. 2016 Jun 17;2(6):e1501678. doi: 10.1126/sciadv.1501678. eCollection 2016 Jun.

43.

The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion.

Hucke S, Herold M, Liebmann M, Freise N, Lindner M, Fleck AK, Zenker S, Thiebes S, Fernandez-Orth J, Buck D, Luessi F, Meuth SG, Zipp F, Hemmer B, Engel DR, Roth J, Kuhlmann T, Wiendl H, Klotz L.

Acta Neuropathol. 2016 Sep;132(3):413-31. doi: 10.1007/s00401-016-1593-6. Epub 2016 Jul 6.

PMID:
27383204
44.

Increased structural white and grey matter network connectivity compensates for functional decline in early multiple sclerosis.

Fleischer V, Gröger A, Koirala N, Droby A, Muthuraman M, Kolber P, Reuter E, Meuth SG, Zipp F, Groppa S.

Mult Scler. 2017 Mar;23(3):432-441. doi: 10.1177/1352458516651503. Epub 2016 Jul 11.

PMID:
27246143
45.

Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.

Sadovnick AD, Traboulsee AL, Bernales CQ, Ross JP, Forwell AL, Yee IM, Guillot-Noel L, Fontaine B, Cournu-Rebeix I, Alcina A, Fedetz M, Izquierdo G, Matesanz F, Hilven K, Dubois B, Goris A, Astobiza I, Alloza I, Antigüedad A, Vandenbroeck K, Akkad DA, Aktas O, Blaschke P, Buttmann M, Chan A, Epplen JT, Gerdes LA, Kroner A, Kubisch C, Kümpfel T, Lohse P, Rieckmann P, Zettl UK, Zipp F, Bertram L, Lill CM, Fernandez O, Urbaneja P, Leyva L, Alvarez-Cermeño JC, Arroyo R, Garagorri AM, García-Martínez A, Villar LM, Urcelay E, Malhotra S, Montalban X, Comabella M, Berger T, Fazekas F, Reindl M, Schmied MC, Zimprich A, Vilariño-Güell C.

G3 (Bethesda). 2016 Jul 7;6(7):2073-9. doi: 10.1534/g3.116.030841.

46.

Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.

Reitz SC, Hof SM, Fleischer V, Brodski A, Gröger A, Gracien RM, Droby A, Steinmetz H, Ziemann U, Zipp F, Deichmann R, Klein JC.

Brain Imaging Behav. 2017 Jun;11(3):744-753. doi: 10.1007/s11682-016-9550-5.

PMID:
27138529
47.

Erratum to: Dendritic cells as therapeutic targets in neuroinflammation.

Luessi F, Zipp F, Witsch E.

Cell Mol Life Sci. 2016 Jul;73(13):2451. No abstract available.

PMID:
27105624
48.

Power estimation for non-standardized multisite studies.

Keshavan A, Paul F, Beyer MK, Zhu AH, Papinutto N, Shinohara RT, Stern W, Amann M, Bakshi R, Bischof A, Carriero A, Comabella M, Crane JC, D'Alfonso S, Demaerel P, Dubois B, Filippi M, Fleischer V, Fontaine B, Gaetano L, Goris A, Graetz C, Gröger A, Groppa S, Hafler DA, Harbo HF, Hemmer B, Jordan K, Kappos L, Kirkish G, Llufriu S, Magon S, Martinelli-Boneschi F, McCauley JL, Montalban X, Mühlau M, Pelletier D, Pattany PM, Pericak-Vance M, Cournu-Rebeix I, Rocca MA, Rovira A, Schlaeger R, Saiz A, Sprenger T, Stecco A, Uitdehaag BMJ, Villoslada P, Wattjes MP, Weiner H, Wuerfel J, Zimmer C, Zipp F; International Multiple Sclerosis Genetics Consortium. Electronic address: AIVINSON@PARTNERS.ORG, Hauser SL, Oksenberg JR, Henry RG.

Neuroimage. 2016 Jul 1;134:281-294. doi: 10.1016/j.neuroimage.2016.03.051. Epub 2016 Apr 1.

49.

Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology?

Larochelle C, Uphaus T, Prat A, Zipp F.

Trends Neurosci. 2016 May;39(5):325-339. doi: 10.1016/j.tins.2016.02.001. Epub 2016 Mar 15. Review.

PMID:
26987259
50.

Dendritic cells as therapeutic targets in neuroinflammation.

Luessi F, Zipp F, Witsch E.

Cell Mol Life Sci. 2016 Jul;73(13):2425-50. doi: 10.1007/s00018-016-2170-9. Epub 2016 Mar 12. Review. Erratum in: Cell Mol Life Sci. 2016 Jul;73(13):2451.

PMID:
26970979

Supplemental Content

Support Center